niraparib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1 (1)
Phase 2 (1)

Interventional (2)

Bayer (1)
University of Pennsylvania (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadcancer

I am/have/hadfallopian tube

I am/have/hadmeasurable disease

I am/have/hadneutrophil count

I am/have/hadmetastasis

I am/have/hadovarian cancer

I am/have/hadprimary peritoneal carcinoma

I am/have/hadperitoneal cancer

I am/have/hadserum pregnancy test

I am/have/hadmalnutrition

I am/have/hadplatelet count

I am/have/hadrenal function

I am/have/hadprostate cancer

I am/have/hadglioblastoma

I am/have/hadrenal function test

I am/have/hadkarnofsky performance status

I am/have/hadrecurrent glioblastoma

I am/have/hadline of therapy

I am/have/hadMRI

I am/have/hadtumor cells

added new label for I am/have/had

more

I am looking for

I am looking forniraparib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Neurology
Recruiting

Niraparib/TTFields in GBM

Evaluating the efficacy and safety of niraparib and Tumor-Treating Fields (TTFields) in recurrent glioblastoma (GBM).

renal function test

karnofsky performance status

recurrent glioblastoma

MRI

glioblastoma

0 views
19 Feb, 2024

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

ATR Inhibitor BAY 1895344 Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

The purpose of the study is to test how well patients with advanced solid tumors and ovarian cancer respond to treatment with BAY1895344 in combination with niraparib. In addition researchers want to find for patients the optimal dose of BAY1895344 in combination with niraparib, how the drug is tolerated and …

measurable disease

metastasis

prostate cancer

primary peritoneal carcinoma

peritoneal cancer

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.